Henderson Group »

Eliem Therapeutics shares owned by Henderson Group

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Henderson Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $23M 3.3M 7.11

More positions owned by Henderson Group

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Mastercard Incorporated Cl A (MA)
UnitedHealth (UNH)
Oracle Corporation (ORCL)
Abbvie (ABBV)
Lam Research Corporation (LRCX)
Booking Holdings (BKNG)
Progressive Corporation (PGR)
Broadcom (AVGO)

View all positions for Henderson Group

Top funds holding Eliem Therapeutics

RA Capital Management
Deep Track Capital
Samsara BioCapital
Henderson Group
Boxer Capital
Affinity Asset Advisors
Driehaus Capital Management
BlackRock
Vanguard Group
Sphera Funds Management
Geode Capital Management
Ikarian Capital
TD Asset Management
State Street Corporation
Segall Bryant & Hamill

View all funds holding Eliem Therapeutics